Real-time enrollment status for this prurigo nodularis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:22 PM UTC
| NCT Number | NCT06366750 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Prurigo Nodularis |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Celldex Therapeutics |
| Last Updated on CT.gov | January 30, 2026 (Jan 30, 2026) |
As of March 2, 2026: Clinical trial NCT06366750 is currently active_not_recruiting participants. This clinical trial study for prurigo nodularis is not currently accepting new participants at 33 locations across the United States. The study is sponsored by Celldex Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06366750 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06366750 was last updated Jan 30, 2026 (January 30, 2026). HelloStudys verifies this status automatically.